In 2025, the U.S. pharmaceutical market is witnessing a surprising surge: a marked increase in sales of Ivermectin 6mg. Once considered a niche antiparasitic drug, Ivermectin has evolved into a subject of heated debate — oscillating between miracle claims and government scrutiny. But why is Ivermectin 6mg, specifically, capturing national attention? As regulatory agencies like the FDA...